Nurse Practitioner in Newbury Park, CA Accepting Medicare

7 Nurse Practitioner nurses found. Showing 1 - 7

Mikey Thanteraphong, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3175 Old Conejo Rd # 200, Newbury Park, CA 91320 Phone: 818-835-7355

Mrs. Bonni Tromello, CFNP Nurse Practitioner - Family Medicare: May Accept Medicare Assignments Practice Location: 558 N Ventu Park Rd, Suite B, Newbury Park, CA 91320 Phone: 805-480-0499    Fax: 805-480-0866

Mrs. Andrea Louise Horita, BSN, RN, MSN, FNP Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 4603 Calle Norte, Newbury Park, CA 91320 Phone: 818-203-7485

Prof. Priscilla Anne Lee, NP Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 3378 Daniel St, Newbury Park, CA 91320 Phone: 805-499-5373    Fax: 805-499-5373

Gina Faruzzi, FNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 4275 Via Entrada, Newbury Park, CA 91320 Phone: 805-358-2810

Amanda J Ball, FNP Nurse Practitioner - Primary Care Medicare: Medicare Enrolled Practice Location: 3184 Lynn Ct, Newbury Park, CA 91320 Phone: 520-465-7277

Gina Marcaccio, NP Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 4679 Via Grande, Newbury Park, CA 91320 Phone: 818-516-1400

News Archive

UMass Amherst biophysicist receives 2013 Margaret Oakley Dayhoff Award

University of Massachusetts Amherst biophysicist Jenny Ross has won one of the top national honors in her field, the 2013 Margaret Oakley Dayhoff Award, from the Biophysical Society of Rockville, Md. It is given to a woman who has achieved prominence for "substantial contributions to science," while showing very high promise for ideas and leadership in the early stages of her biophysical research career.

IRIS announces product acquisition from BioMicro Systems

IRIS International, Inc., a leading manufacturer of automated in-vitro diagnostics systems and a provider of high value personalized medicine products and testing services, announced today that it has acquired the assets of a multi-purpose, bench-top instrument platform for automating highly repetitive, manual laboratory protocols for (F)ISH (fluorescence in-situ hybridization) testing and other slide-based cytogenetic applications.

Molecular signatures can predict flu vaccine responses in young and old

What factors inhibit strong responses to seasonal flu vaccines in the elderly? Why do anti-flu antibodies last longer after vaccination in some people? Answers are emerging from an Emory University-based systems biology analysis of blood samples from more than 400 volunteers who received seasonal flu vaccines. Bali Pulendran, PhD, led a team of researchers who tracked patterns of gene expression, known as molecular signatures, of strong immune responses in volunteers' blood across five consecutive seasons from 2007 to 2011.

Cerenis Therapeutics closes first round of series C, raises €40 million

Cerenis Therapeutics SA (Cerenis), a biopharmaceutical company specializing in the research and development of novel therapies based on the metabolism of HDL (the "good" cholesterol) to treat cardiovascular and other metabolic diseases, announced today it has raised €40 million in the first close of its series C financing. In this round €20 million came from the Fund for Strategic Investment (FSI) with an additional €20 million coming from the existing investors: Sofinnova Partners, HealthCap, Alta Partners and TVM Capital, EDF Ventures, OrbiMed and DAIWA Corporate Investment.

Read more Medical News

› Verified 5 days ago